CS
BDSX icon

Cannell & Spears’s Biodesix BDSX Stock Holding History

Cannell & Spears’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+8,921
New +$132K ﹤0.01% 428
2025
Q4 		– Sell
-10,279
Closed -$77.6K – 414
2025
Q3 		$77.6K Sell
10,279
-1
-0% -$8 ﹤0.01% 397
2025
Q2 		$58K Hold
10,280
– – ﹤0.01% 390
2025
Q1 		$129K Hold
10,280
– – ﹤0.01% 377
2024
Q4 		$315K Hold
10,280
– – 0.01% 332
2024
Q3 		$366K Hold
10,280
– – 0.01% 326
2024
Q2 		$315K Hold
10,280
– – 0.01% 303
2024
Q1 		$294K Buy
+10,280
New +$352K 0.01% 320

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Cannell & Spears's BDSX Position: Q2 2026 in Review

Cannell & Spears opened a new position in Biodesix (BDSX) in Q2 2026: 8,921 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #428 among its holdings. This is a return to the name: Cannell & Spears previously reported a position in BDSX as recently as Q3 2025.

Cannell & Spears first reported a position in BDSX in Q1 2024 and has held it in 8 quarters since. The position peaked at $366K in Q3 2024. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Cannell & Spears held 8,921 shares of Biodesix worth $201K as of Q2 2026.
  • Biodesix was a new Cannell & Spears position in Q2 2026.
  • Biodesix made up ﹤0.01% of Cannell & Spears's portfolio in Q2 2026, its #428 holding.
  • Cannell & Spears first reported a position in Biodesix in Q1 2024 and has held it in 8 quarters since.
  • Cannell & Spears's Biodesix position peaked at $366K in Q3 2024.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Cannell & Spears's 13F filing for Q2 2026, filed 11 Aug 2026.